Belgian Industrial REITs Stock News

Argenx received a priority FDA review for a supplemental Vyvgart application that could broaden its use to more patients. The company is advancing plans to expand Vyvgart into additional autoimmune indications and new delivery approaches. Management is using recent commercial traction to support wider global rollout and deepen the Vyvgart franchise. For investors tracking ENXTBR:ARGX, the focus now is on how this priority review and broader Vyvgart push fit with the share price of €710.0...

UBS Group AG has fallen below the 3% voting rights threshold in Solvay (ENXTBR:SOLB), according to recent Belgian transparency notifications. The change reflects an adjustment in UBS Group AG's shareholding that may matter for investors tracking Solvay's ownership profile. Solvay, a Belgium based chemicals group, operates in specialty materials, energy transition themes and a wide range of industrial end markets. For you as an investor, shifts in the register involving large institutions...

Key Insights Significant control over Melexis by retail investors implies that the general public has more power to...

As Europe navigates renewed trade tensions and geopolitical uncertainties, the pan-European STOXX Europe 600 Index has seen a decline, reflecting broader market challenges. Despite this backdrop, business activity in the eurozone remains positive with heightened optimism in the business outlook, offering potential opportunities for growth-focused investors. In such an environment, companies with strong insider ownership can be particularly appealing as they often indicate confidence from...

The Lotus Bakeries NV ( EBR:LOTB ) share price has done very well over the last month, posting an excellent gain of...

The Cmb.Tech NV ( EBR:CMBT ) share price has done very well over the last month, posting an excellent gain of 26...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...

Barco recently launched weConnect, a cloud-based collaborative learning platform for higher education that supports device connectivity, remote participation, and teacher moderation through a simple web app. The move highlights how Barco is targeting digitally enabled, student-centric learning environments, positioning its technology more directly within the evolving education-technology ecosystem. We will now explore how the higher-education focus of weConnect could shape Barco’s broader...

Why Warehouses De Pauw just caught investors' attention Warehouses De Pauw (ENXTBR:WDP) reaffirmed its guidance for like-for-like rental growth and reported occupancy that remains close to fully let, which keeps the focus firmly on the resilience of its logistics portfolio. See our latest analysis for Warehouses De Pauw. With the share price at €22.98, Warehouses De Pauw has seen a 6.19% 1 month share price return and a 4.26% year to date share price return, while the 1 year total shareholder...

VGP NV recently reported the past completion of its capped tender offer for its outstanding €500,000,000 1.625% green bonds due January 2027, accepting €100,000,000 of the €320,100,000 then outstanding and confirming that the New Issue Condition was met. This move highlights VGP’s active approach to managing its green bond liabilities and refining its capital structure through selective early repayment. Next, we will explore how this targeted €100,000,000 green bond buyback shapes VGP’s...

SCR-Sibelco: recent share performance and business scale SCR-Sibelco (ENXTBR:094426466) has drawn investor attention after recent share moves, with the stock showing a month return of 12.73% decline and a past 3 months return of 2.04% decline. The company last closed at €4,800.00, with reported revenue of €2.3b and net income of €63.378m. This indicates a sizeable global industrial minerals business headquartered in Antwerp and operating across multiple regions. See our latest analysis for...

Key Insights The considerable ownership by retail investors in Syensqo indicates that they collectively have a greater...

Cenergy Holdings SA ( EBR:CENER ) shareholders have had their patience rewarded with a 28% share price jump in the last...

In recent weeks, the European market has experienced a downturn, with the pan-European STOXX Europe 600 Index declining by 0.98% amid ongoing trade and geopolitical uncertainties. Despite this backdrop, business activity in the eurozone shows modest expansion and increased optimism, presenting opportunities for discerning investors to identify stocks with robust fundamentals that can weather such volatility. When evaluating potential investments in this environment, it is crucial to focus on...

UCB previously announced that it would receive capital support from the UK government’s Life Sciences Innovative Manufacturing Fund as part of a joint investment of around £500 million to expand its R&D activities at the Windlesham, Surrey research hub. This funding underscores how the UK’s research infrastructure has become integral to UCB’s discovery engine, with several of its treatments originating from UK-based laboratories. We will now consider how this UK government-backed R&D...

AB InBev has secured an exclusive beer and cider partnership with Live Nation in the UK. The agreement connects AB InBev brands to major music festivals and venues, targeting millions of attendees. The partnership focuses on immersive on site experiences and expanded visibility for the brewer's portfolio. For investors watching Anheuser-Busch InBev, ticker ENXTBR:ABI, this Live Nation deal links a global brewer with one of the UK's largest live entertainment platforms. With the current...

Argenx (ENXTBR:ARGX) is back in focus after the U.S. Food and Drug Administration accepted a priority review for a supplemental Biologics License Application for VYVGART in seronegative generalized myasthenia gravis. See our latest analysis for argenx. The FDA priority review has arrived after a year where argenx’s share price has been relatively muted in the short term, with a 30 day share price return of 2.45% decline and year to date share price return of 3.15% decline. However, the 1 year...

DEME has taken delivery of its second new wind turbine installation vessel, Norse Energi, from CIMC Raffles Shipyard, a purpose-built ship designed to handle the next generation of large-scale offshore wind turbines with advanced lifting, loading, and sustainability features. By pairing Norse Energi with its sister vessel Norse Wind, DEME is expanding a specialized fleet that could enhance its role in complex offshore wind installation projects worldwide. We will now examine how this...

AB InBev’s Live Nation deal puts its brands at UK music forefront Anheuser-Busch InBev (ENXTBR:ABI) has been named exclusive beer and cider partner for Live Nation’s UK festivals and venues, connecting Budweiser, Corona, Stella Artois and others with millions of concert and festival goers. See our latest analysis for Anheuser-Busch InBev. The Live Nation agreement lands as Anheuser-Busch InBev’s recent 30-day share price return of 8.28% and 90-day share price return of 11.60% contrast with a...

Earlier in 2026, Belgium-based insurer Ageas raised its full-year guidance after China Taiping Insurance Holding’s updated tax treatment under IFRS 17/9 implied a positive one-off impact via their Taiping Life joint venture. This combination of stronger guidance and a tax-related uplift in China underscores management’s confidence in both core insurance operations and cross-border partnerships. We’ll now explore how the upgraded guidance, underpinned by the one-off tax benefit in China,...

KBC Bank has launched Bitcoin and Ethereum trading for retail customers via its Bolero investment platform, becoming Belgium’s first bank to offer crypto trading under the EU’s Markets in Crypto-Assets (MiCA) regulation. The move positions KBC as an early adopter of regulated digital asset services in European banking, giving clients crypto exposure without allowing transfers to external wallets. We’ll now examine how this MiCA-compliant crypto launch shapes KBC Group’s investment narrative...

Viohalco (EBR:VIO) has had a great run on the share market with its stock up by a significant 52% over the last three...

argenx SE recently announced that the U.S. FDA has accepted for priority review a supplemental Biologics License Application for VYVGART to treat adults with acetylcholine receptor antibody seronegative generalized myasthenia gravis, supported by the Phase 3 ADAPT SERON study that met its primary endpoint. This filing, which covers all three seronegative gMG subtypes (MuSK+, LRP4+, and triple seronegative), highlights an effort to expand treatment options for a group of patients with fewer...

Key Insights Given the large stake in the stock by institutions, Azelis Group's stock price might be vulnerable to...